{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:18:54Z","timestamp":1793157534026,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Colorectal cancer (CRC) is a leading cause of cancer-related deaths and obesity is a known risk factor for its development and poor prognosis. Adipose tissue (AT) actively contributes to CRC progression and cachexia. Here, we investigated molecular crosstalk between tumor cells and different visceral AT depots (normal, intra- and peri-tumoral), focusing on metabolic and (epi)genetic alterations. Using WGS analysis, we explored VAT role in CRC progression, demonstrating how its proximity to the tumor impacts metabolic and phenotypic changes. Intra-VAT (within 5\u2009cm of lesion), closest to the tumor, underwent significant metabolic remodeling, characterized by upregulation of markers of the white-brown AT transition (UCP-1, TMEM26), lipid metabolism (PON3) and a reduction in adipocyte turnover (Pref-1, adiponectin). Peri-VAT (within 15\u2009cm) and HVAT (over 15\u2009cm) exhibited progressively fewer alterations, suggesting a gradient effect of tumor on surrounding AT. Intra-VAT displayed increased fibrosis (TGF-\u03b2, collagen) and cachexia-related markers (IL-8), and mutations in key oncogenes (KRAS, HLA, MET), highlighting a direct interaction between tumor cells and AT driving CRC progression. Mutations in genes such as KRAS, HLA, and PIK3CA were shared between CRC and its Intra-VAT, indicating potential biomarkers for tumor progression and immune evasion. miRNA analysis revealed upregulation of miR-21 and miR-92a in Intra-VAT, with circulating miR-92a correlating with increased body fat and decreased lean mass in CRC patients, suggesting their involvement in both local metabolic remodeling and systemic changes. Altered PON3 DNA methylation patterns were also observed, correlating with metabolic parameters. Our findings underscore AT\u2019s critical role in the CRC microenvironment as an active player in CRC progression and cachexia. Metabolic and genetic alterations decreased in VAT with increasing distance from the tumor. Intra-VAT may serve as a critical therapeutic target and biomarker for CRC progression, impacting surgical and postoperative strategies. Future studies should focus on targeting tumor-adipose crosstalk to improve treatment outcomes, including experimental validation of the identified genetic alterations and investigation of their functional roles in tumor progression and immune evasion.<\/jats:p>","DOI":"10.1038\/s41419-025-07982-6","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:19:42Z","timestamp":1759731582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5541-8255","authenticated-orcid":false,"given":"Ada","family":"Pesapane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Del Sorbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-4298","authenticated-orcid":false,"given":"Lucia","family":"Scisciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Puocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surina","family":"Surina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Fuschillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Selvaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5225-3364","authenticated-orcid":false,"given":"Rosaria Anna","family":"Fontanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-5540","authenticated-orcid":false,"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Selvaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-5387","authenticated-orcid":false,"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-455X","authenticated-orcid":false,"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-5792","authenticated-orcid":false,"given":"Michelangela","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Nebbioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"7982_CR1","doi-asserted-by":"crossref","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, et al. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers (Basel). 14 2022.","DOI":"10.3390\/cancers14071732"},{"key":"7982_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21037\/atm.2017.04.45","volume":"5","author":"E Danese","year":"2017","unstructured":"Danese E, Montagnana M. Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers. Ann Transl Med. 2017;5:279.","journal-title":"Ann Transl Med"},{"key":"7982_CR3","doi-asserted-by":"crossref","unstructured":"Tiffon C. The impact of nutrition and environmental epigenetics on human health and disease. Int J Mol Sci. 2018;19.","DOI":"10.3390\/ijms19113425"},{"key":"7982_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0772-5","volume":"14","author":"J Martinez-Useros","year":"2016","unstructured":"Martinez-Useros J, Garcia-Foncillas J. Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med. 2016;14:21.","journal-title":"J Transl Med"},{"key":"7982_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/endrev\/bnad015","volume":"44","author":"KA Brown","year":"2023","unstructured":"Brown KA, Scherer PE. Update on adipose tissue and cancer. Endocr Rev. 2023;44:961\u201374.","journal-title":"Endocr Rev"},{"key":"7982_CR6","doi-asserted-by":"crossref","unstructured":"Mariean CR, Tiuc\u0103 OM, Mariean A, Cotoi OS. Cancer cachexia: new insights and future directions. Cancers (Basel). 2023;15.","DOI":"10.3390\/cancers15235590"},{"key":"7982_CR7","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184\u2013223.","journal-title":"Int J Mol Sci"},{"key":"7982_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jcsm.12037","volume":"7","author":"ML Batista Jr.","year":"2016","unstructured":"Batista ML Jr., Henriques FS, Neves RX, Olivan MR, Matos-Neto EM, Alc\u00e2ntara PS, et al. Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients. J Cachexia Sarcopenia Muscle. 2016;7:37\u201347.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7982_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/JOE-12-0307","volume":"215","author":"ML Batista Jr","year":"2012","unstructured":"Batista ML Jr, Neves RX, Peres SB, Yamashita AS, Shida CS, Farmer SR, et al. Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia. J Endocrinol. 2012;215:363\u201373.","journal-title":"J Endocrinol"},{"key":"7982_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41\u20135.","journal-title":"Nature"},{"key":"7982_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"7982_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"7982_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2020;31:62\u201376.","journal-title":"Cell Metab"},{"key":"7982_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","volume":"17","author":"J Han","year":"2018","unstructured":"Han J, Meng Q, Shen L, Wu G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 2018;17:14.","journal-title":"Lipids Health Dis"},{"key":"7982_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, Allen J, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014;20:433\u201347.","journal-title":"Cell Metab"},{"key":"7982_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89:381\u2013410.","journal-title":"Physiol Rev"},{"key":"7982_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1615\/CritRevOncog.v17.i3.70","volume":"17","author":"A Vigano","year":"2012","unstructured":"Vigano A, Del Fabbro E, Bruera E, Borod M. The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog. 2012;17:293\u2013303.","journal-title":"Crit Rev Oncog"},{"key":"7982_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/PPO.0000000000000100","volume":"21","author":"MF Penet","year":"2015","unstructured":"Penet MF, Bhujwalla ZM. Cancer cachexia, recent advances, and future directions. Cancer J. 2015;21:117\u201322.","journal-title":"Cancer J"},{"key":"7982_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.793428","volume":"9","author":"M Huo","year":"2021","unstructured":"Huo M, Zhang J, Huang W, Wang Y. Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer. Front Cell Dev Biol. 2021;9:793428.","journal-title":"Front Cell Dev Biol"},{"key":"7982_CR20","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jcsm.13224","volume":"14","author":"T Krauss","year":"2023","unstructured":"Krauss T, Heisz S, Honecker J, Prokopchuk O, Martignoni M, Janssen KP, et al. Specific miRNAs are associated with human cancer cachexia in an organ-specific manner. J Cachexia Sarcopenia Muscle. 2023;14:1381\u201394.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7982_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.563816","volume":"11","author":"GS Heyn","year":"2020","unstructured":"Heyn GS, Corr\u00eaa LH, Magalh\u00e3es KG. The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. Front Endocrinol (Lausanne). 2020;11:563816.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7982_CR22","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1073\/pnas.0800178105","volume":"105","author":"Q Wang","year":"2008","unstructured":"Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg RJ, et al. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2\/p130. Proc Natl Acad Sci USA. 2008;105:2889\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7982_CR23","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1002\/jcb.29539","volume":"121","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Jiang H, Li X, Chen X, Huang Y. MiR-92a regulates brown adipocytes differentiation, mitochondrial oxidative respiration, and heat generation by targeting SMAD7. J Cell Biochem. 2020;121:3825\u201336.","journal-title":"J Cell Biochem"},{"key":"7982_CR24","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1002\/stem.235","volume":"27","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Hwang SJ, Bae YC, Jung JS. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. 2009;27:3093\u2013102.","journal-title":"Stem Cells"},{"key":"7982_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.omtn.2021.06.019","volume":"26","author":"S Lhamyani","year":"2021","unstructured":"Lhamyani S, Gentile AM, Gir\u00e1ldez-P\u00e9rez RM, Feij\u00f3o-Cuaresma M, Romero-Zerbo SY, Clemente-Postigo M, et al. miR-21 mimic blocks obesity in mice: A novel therapeutic option. Mol Ther Nucleic Acids. 2021;26:401\u201316.","journal-title":"Mol Ther Nucleic Acids"},{"key":"7982_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/15592294.2019.1595297","volume":"14","author":"M Samblas","year":"2019","unstructured":"Samblas M, Milagro FI, Mart\u00ednez A. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics. 2019;14:421\u201344.","journal-title":"Epigenetics"},{"key":"7982_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15592294.2021.1873629","volume":"17","author":"F Salas-P\u00e9rez","year":"2022","unstructured":"Salas-P\u00e9rez F, Cuevas-Sierra A, Cuervo M, Goni L, Milagro FI, Mart\u00ednez JA, et al. Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity. Epigenetics. 2022;17:81\u201392.","journal-title":"Epigenetics"},{"key":"7982_CR28","doi-asserted-by":"crossref","unstructured":"Mohammed CJ, Lamichhane S, Connolly JA, Soehnlen SM, Khalaf FK, Malhotra D, et al. A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease. Antioxidants (Basel). 2022;11.","DOI":"10.3390\/antiox11030590"},{"key":"7982_CR29","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/nm.3361","volume":"19","author":"M Harms","year":"2013","unstructured":"Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19:1252\u201363.","journal-title":"Nat Med"},{"key":"7982_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00015.2003","volume":"84","author":"B Cannon","year":"2004","unstructured":"Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277\u2013359.","journal-title":"Physiol Rev"},{"key":"7982_CR31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ijosup.2015.4","volume":"5","author":"S Kajimura","year":"2015","unstructured":"Kajimura S. Promoting brown and beige adipocyte biogenesis through the PRDM16 pathway. Int J Obes Suppl. 2015;5:S11\u20134.","journal-title":"Int J Obes Suppl"},{"key":"7982_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","volume":"150","author":"J Wu","year":"2012","unstructured":"Wu J, Bostr\u00f6m P, Sparks LM, Ye L, Choi JH, Giang AH, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150:366\u201376.","journal-title":"Cell"},{"key":"7982_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.mol.0000174398.84185.0f","volume":"16","author":"M Aviram","year":"2005","unstructured":"Aviram M, Rosenblat M. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipido. 2005;16:393\u20139.","journal-title":"Curr Opin Lipido"},{"key":"7982_CR34","doi-asserted-by":"crossref","unstructured":"Priyanka K, Singh S, Gill K. Paraoxonase 3: structure and its role in pathophysiology of coronary artery disease. Biomolecules. 9;2019.","DOI":"10.3390\/biom9120817"},{"key":"7982_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0092-8674(93)90252-L","volume":"73","author":"CM Smas","year":"1993","unstructured":"Smas CM, Sul HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell. 1993;73:725\u201334.","journal-title":"Cell"},{"key":"7982_CR36","doi-asserted-by":"publisher","first-page":"E1230","DOI":"10.1152\/ajpendo.90927.2008","volume":"296","author":"MJ Lee","year":"2009","unstructured":"Lee MJ, Fried SK. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. Am J Physiol Endocrinol Metab. 2009;296:E1230\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7982_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165:535\u201350.","journal-title":"Cell"},{"key":"7982_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc2824","volume":"10","author":"D Silvera","year":"2010","unstructured":"Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer. 2010;10:254\u201366.","journal-title":"Nat Rev Cancer"},{"key":"7982_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03106-1","volume":"9","author":"T Mathieson","year":"2018","unstructured":"Mathieson T, Franken H, Kosinski J, Kurzawa N, Zinn N, Sweetman G, et al. Systematic analysis of protein turnover in primary cells. Nat Commun. 2018;9:689.","journal-title":"Nat Commun"},{"key":"7982_CR40","doi-asserted-by":"publisher","first-page":"1935s","DOI":"10.1093\/jn\/136.7.1935S","volume":"136","author":"P Trayhurn","year":"2006","unstructured":"Trayhurn P, Bing C, Wood IS. Adipose tissue and adipokines\u2013energy regulation from the human perspective. J Nutr. 2006;136:1935s\u20139s.","journal-title":"J Nutr"},{"key":"7982_CR41","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/nm.3324","volume":"19","author":"QA Wang","year":"2013","unstructured":"Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med. 2013;19:1338\u201344.","journal-title":"Nat Med"},{"key":"7982_CR42","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41418-018-0111-x","volume":"25","author":"CH Wilson","year":"2018","unstructured":"Wilson CH, Kumar S. Caspases in metabolic disease and their therapeutic potential. Cell Death Differ. 2018;25:1010\u201324.","journal-title":"Cell Death Differ"},{"key":"7982_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395\u2013406.","journal-title":"J Cell Biol"},{"key":"7982_CR44","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15:1243\u201353.","journal-title":"EMBO Rep."},{"key":"7982_CR45","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15:786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7982_CR46","doi-asserted-by":"crossref","unstructured":"Shen X, Ye Z, Wu W, Zhao K, Cheng G, Xu L, et al. lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A\/Cul4A and Wnt signaling pathway. Int J Oncol. 59 2021.","DOI":"10.3892\/ijo.2021.5231"},{"key":"7982_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01700-2","volume":"21","author":"Y Leng","year":"2021","unstructured":"Leng Y, Chen Z, Ding H, Zhao X, Qin L, Pan Y. Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4\/ERK\/EGFR axis. Cancer Cell Int. 2021;21:17.","journal-title":"Cancer Cell Int"},{"key":"7982_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1634\/theoncologist.2018-0117","volume":"24","author":"A Puccini","year":"2019","unstructured":"Puccini A, Lenz HJ, Marshall JL, Arguello D, Raghavan D, Korn WM, et al. Impact of patient age on molecular alterations of left-sided colorectal tumors. Oncologist. 2019;24:319\u201326.","journal-title":"Oncologist"},{"key":"7982_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/01.fpc.0000165904.48994.3d","volume":"15","author":"S Landi","year":"2005","unstructured":"Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics. 2005;15:535\u201346.","journal-title":"Pharmacogenet Genomics"},{"key":"7982_CR50","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gutjnl-2012-302423","volume":"62","author":"S Tian","year":"2013","unstructured":"Tian S, Simon I, Moreno V, Roepman P, Tabernero J, Snel M, et al. A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction. Gut. 2013;62:540\u20139.","journal-title":"Gut"},{"key":"7982_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/dmpt-2024-0033","volume":"39","author":"P Ariyannur","year":"2024","unstructured":"Ariyannur P, Menon VP, Pavithran K, Paulose RR, Joy RA, Vasudevan DM. Molecular pathogenesis of microsatellite instability-high early-stage colorectal adenocarcinoma in India. Drug Metab Pers Ther. 2024;39:125\u201335.","journal-title":"Drug Metab Pers Ther"},{"key":"7982_CR52","doi-asserted-by":"publisher","first-page":"1268117","DOI":"10.3389\/fimmu.2023.1268117","volume":"14","author":"YY Tsai","year":"2023","unstructured":"Tsai YY, Qu C, Bonner JD, Sanz-Pamplona R, Lindsey SS, Melas M, et al. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer. Front Immunol. 2023;14:1268117.","journal-title":"Front Immunol"},{"key":"7982_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6:254.","journal-title":"Signal Transduct Target Ther"},{"key":"7982_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.869263","volume":"9","author":"A Lin","year":"2022","unstructured":"Lin A, Qi C, Li M, Guan R, Imyanitov EN, Mitiushkina NV, et al. Deep Learning Analysis of the Adipose Tissue and the Prediction of Prognosis in Colorectal Cancer. Front Nutr. 2022;9:869263.","journal-title":"Front Nutr"},{"key":"7982_CR55","doi-asserted-by":"crossref","unstructured":"M\u00e1rmol I, S\u00e1nchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18010197"},{"key":"7982_CR56","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.7150\/thno.55609","volume":"11","author":"KL Zhang","year":"2021","unstructured":"Zhang KL, Zhu WW, Wang SH, Gao C, Pan JJ, Du ZG, et al. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Theranostics. 2021;11:6560\u201372.","journal-title":"Theranostics"},{"key":"7982_CR57","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.biopha.2016.05.034","volume":"82","author":"H Shali","year":"2016","unstructured":"Shali H, Ahmadi M, Kafil HS, Dorosti A, Yousefi M. IGF1R and c-met as therapeutic targets for colorectal cancer. Biomed Pharmacother. 2016;82:528\u201336.","journal-title":"Biomed Pharmacother"},{"key":"7982_CR58","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1016\/j.ajpath.2011.08.007","volume":"179","author":"S Uddin","year":"2011","unstructured":"Uddin S, Hussain AR, Ahmed M, Al-Sanea N, Abduljabbar A, Ashari LH, et al. Coexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma. Am J Pathol. 2011;179:3032\u201344.","journal-title":"Am J Pathol"},{"key":"7982_CR59","doi-asserted-by":"crossref","unstructured":"Myte R, Harlid S, Sundkvist A, Gylling B, H\u00e4ggstr\u00f6m J, Zingmark C, et al. A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer. Sci Rep. 2020;10:5336.","DOI":"10.1038\/s41598-020-62129-1"},{"key":"7982_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1615\/CritRevOncog.2020035067","volume":"25","author":"B Dariya","year":"2020","unstructured":"Dariya B, Aliya S, Merchant N, Alam A, Nagaraju GP. Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches. Crit Rev Oncog. 2020;25:71\u201394.","journal-title":"Crit Rev Oncog"},{"key":"7982_CR61","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41423-021-00634-7","volume":"18","author":"P Anderson","year":"2021","unstructured":"Anderson P, Aptsiauri N, Ruiz-Cabello F, Garrido F. HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy. Cell Mol Immunol. 2021;18:556\u201365.","journal-title":"Cell Mol Immunol"},{"key":"7982_CR62","doi-asserted-by":"crossref","unstructured":"Tkachenko A, Kupcova K, Havranek O B-Cell Receptor Signaling and Beyond: The Role of Ig\u03b1 (CD79a)\/Ig\u03b2 (CD79b) in Normal and Malignant B Cells. Int J Mol Sci.;25 2023.","DOI":"10.3390\/ijms25010010"},{"key":"7982_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107436","volume":"136","author":"BK Seon","year":"2024","unstructured":"Seon BK, Okazaki M, Duzen J, Matsuno F, Goey AKL, Maguire O. Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b. Leuk Res. 2024;136:107436.","journal-title":"Leuk Res"},{"key":"7982_CR64","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/carcin\/21.3.379","volume":"21","author":"KR Loeb","year":"2000","unstructured":"Loeb KR, Loeb LA. Significance of multiple mutations in cancer. Carcinogenesis. 2000;21:379\u201385.","journal-title":"Carcinogenesis"},{"key":"7982_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101101","volume":"14","author":"A Kottorou","year":"2021","unstructured":"Kottorou A, Dimitrakopoulos FI, Tsezou A. Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives. Transl Oncol. 2021;14:101101.","journal-title":"Transl Oncol"},{"key":"7982_CR66","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1530\/JOE-16-0305","volume":"232","author":"FO Franco","year":"2017","unstructured":"Franco FO, Lopes MA, Henriques FS, Neves RX, Bianchi Filho C, Batista ML Jr. Cancer cachexia differentially regulates visceral adipose tissue turnover. J Endocrinol. 2017;232:493\u2013500.","journal-title":"J Endocrinol"},{"key":"7982_CR67","doi-asserted-by":"publisher","first-page":"14031","DOI":"10.1074\/jbc.M110.102855","volume":"285","author":"B Gustafson","year":"2010","unstructured":"Gustafson B, Smith U. Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem. 2010;285:14031\u201341.","journal-title":"J Biol Chem"},{"key":"7982_CR68","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11695-019-04104-y","volume":"30","author":"R Cereijo","year":"2020","unstructured":"Cereijo R, Taxer\u00e5s SD, Piquer-Garcia I, Pellitero S, Mart\u00ednez E, Tarasc\u00f3 J, et al. Elevated levels of circulating miR-92a are associated with impaired glucose homeostasis in patients with obesity and correlate with metabolic status after bariatric surgery. Obes Surg. 2020;30:174\u20139.","journal-title":"Obes Surg"},{"key":"7982_CR69","doi-asserted-by":"publisher","first-page":"e0300420","DOI":"10.1371\/journal.pone.0300420","volume":"19","author":"A M\u00e9ndez-Mancilla","year":"2024","unstructured":"M\u00e9ndez-Mancilla A, Turij\u00e1n-Espinoza E, Vega-C\u00e1rdenas M, Hern\u00e1ndez-Hern\u00e1ndez GE, Uresti-Rivera EE, Vargas-Morales JM, et al. miR-21, miR-221, miR-29 and miR-34 are distinguishable molecular features of a metabolically unhealthy phenotype in young adults. PLoS One. 2024;19:e0300420.","journal-title":"PLoS One"},{"key":"7982_CR70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/j.2040-4603.2018.tb00006.x","volume":"8","author":"AJ Cozzo","year":"2017","unstructured":"Cozzo AJ, Fuller AM, Makowski L. Contribution of adipose tissue to development of cancer. Compr Physiol. 2017;8:237\u201382.","journal-title":"Compr Physiol"},{"key":"7982_CR71","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606\u201319.","journal-title":"Nat Rev Genet"},{"key":"7982_CR72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1947601911408079","volume":"2","author":"E Castellano","year":"2011","unstructured":"Castellano E, Downward J. RAS interaction with PI3K: more than just another effector pathway. Genes Cancer. 2011;2:261\u201374.","journal-title":"Genes Cancer"},{"key":"7982_CR73","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V96.10.3569","volume":"96","author":"SA Riemersma","year":"2000","unstructured":"Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood. 2000;96:3569\u201377.","journal-title":"Blood"},{"key":"7982_CR74","doi-asserted-by":"crossref","unstructured":"Hazini A, Fisher K, Seymour L. Deregulation of HLA-I in cancer and its central importance for immunotherapy. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2021-002899"},{"key":"7982_CR75","doi-asserted-by":"crossref","unstructured":"Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. A Review of the Important Role of CYP2D6 in Pharmacogenomics. Genes (Basel). 2020;11.","DOI":"10.3390\/genes11111295"},{"key":"7982_CR76","doi-asserted-by":"publisher","first-page":"e0257072","DOI":"10.1371\/journal.pone.0257072","volume":"16","author":"ZI Khamis","year":"2021","unstructured":"Khamis ZI, Pang X, Cui Z, Sang QA, Zhang J. Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity. PLoS ONE. 2021;16:e0257072.","journal-title":"PLoS ONE"},{"key":"7982_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Prim. 2018;4:17105.","journal-title":"Nat Rev Dis Prim"},{"key":"7982_CR78","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"7982_CR79","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, et al. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell. 2018;33:125\u201336. e3.","journal-title":"Cancer Cell"},{"key":"7982_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/PPO.0000000000000127","volume":"21","author":"Z Werb","year":"2015","unstructured":"Werb Z, Lu P. The role of stroma in tumor development. Cancer J. 2015;21:250\u20133.","journal-title":"Cancer J"},{"key":"7982_CR81","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1152\/ajpendo.00485.2005","volume":"292","author":"Z Wang","year":"2007","unstructured":"Wang Z, Heshka S, Wang J, Gallagher D, Deurenberg P, Chen Z, et al. Metabolically active portion of fat-free mass: a cellular body composition level modeling analysis. Am J Physiol Endocrinol Metab. 2007;292:E49\u201353.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7982_CR82","doi-asserted-by":"crossref","unstructured":"Ellez HI, Keskinkilic M, Semiz HS, Arayici ME, K\u0131sa E, Oztop I. The prognostic nutritional index (PNI): a new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma. J Clin Med. 2023;12.","DOI":"10.20944\/preprints202305.1572.v1"},{"key":"7982_CR83","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.clnu.2017.03.021","volume":"37","author":"M Rondanelli","year":"2018","unstructured":"Rondanelli M, Talluri J, Peroni G, Donelli C, Guerriero F, Ferrini K, et al. Beyond Body Mass Index. Is the Body Cell Mass Index (BCMI) a useful prognostic factor to describe nutritional, inflammation and muscle mass status in hospitalized elderly?: Body Cell Mass Index links in elderly. Clin Nutr. 2018;37:934\u20139.","journal-title":"Clin Nutr"},{"key":"7982_CR84","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00432-014-1799-8","volume":"141","author":"T Ikeya","year":"2015","unstructured":"Ikeya T, Shibutani M, Maeda K, Sugano K, Nagahara H, Ohtani H, et al. Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer. J Cancer Res Clin Oncol. 2015;141:307\u201313.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7982_CR85","first-page":"29","volume":"15","author":"E Cereda","year":"2012","unstructured":"Cereda E. Mini nutritional assessment. Curr Opin Clin Nutr Metab Care. 2012;15:29\u201341.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"7982_CR86","doi-asserted-by":"crossref","unstructured":"Reber E, Gomes F, Vasiloglou MF, Schuetz P, Stanga Z. Nutritional risk screening and assessment. J Clin Med.;8 2019.","DOI":"10.3390\/jcm8071065"},{"key":"7982_CR87","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Conesa MT, Philippou E, Pafilas C, Massaro M, Quarta S, Andrade V, et al. Exploring the Validity of the 14-Item Mediterranean Diet Adherence Screener (MEDAS): A Cross-National Study in Seven European Countries around the Mediterranean Region. Nutrients. 2020;12.","DOI":"10.3390\/nu12102960"},{"key":"7982_CR88","doi-asserted-by":"crossref","unstructured":"de F\u00e1tima Ribeiro Silva C, Ohara DG, Matos AP, Pinto A, Pegorari MS. Short physical performance battery as a measure of physical performance and mortality predictor in older adults: a comprehensive literature review. Int J Environ Res Public Health. 2021;18.","DOI":"10.3390\/ijerph182010612"},{"key":"7982_CR89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19:4\u201323.","journal-title":"J Mol Diagn"},{"key":"7982_CR90","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1002\/cphg.98","volume":"106","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yao Y, He H, Shen J. Clinical interpretation of sequence variants. Curr Protoc Hum Genet. 2020;106:e98.","journal-title":"Curr Protoc Hum Genet"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07982-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07982-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07982-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:09:46Z","timestamp":1759777786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07982-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7982"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07982-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Studies using human specimens were approved by the Ethics Committee of University of Campania Luigi Vanvitelli (no. 187\/2020-16436\/2020). The patients provided written informed consent to the use of their resected tissues for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICAL APPROVAL AND CONSENT TO PARTICIPATE"}}],"article-number":"675"}}